New program aims to help hospitalized smokers kick the habit for good

NCT ID NCT05733767

Recruiting now Disease control Sponsor: Baystate Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a personalized smoking cessation program for smokers admitted to the hospital with heart or lung disease. Participants receive tailored medication, counseling, and text message support to help them quit and stay smoke-free. The goal is to see if this approach leads to more people using effective quit-smoking medicines and actually stopping smoking long-term.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: smoking cessation pharmacotherapy (varenicline or nicotine patch plus lozenge/gum/inhaler)
What this could lead to: If successful, this could provide a proven, cost-effective way to help hospitalized smokers with heart or lung disease quit for good, reducing relapse and improving health outcomes.
What could go wrong: This is a Phase 2 trial with 424 participants at one hospital, so results may not apply to all smokers. The program relies on patient motivation and follow-up, which may be challenging.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute asthma acute coronary syndrome chronic obstructive pulmonary disease cor pulmonale heart failure myocardial infarction Smoking Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOPULMONARY DISEASE INPATIENT SMOKING CESSATION

Contacts and locations

Locations

Baystate Medical Center
RECRUITING

Springfield, Massachusetts, 01199, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.